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Specificity in Trk Receptor:Neurotrophin
Interactions: The Crystal Structure of TrkB-d5
in Complex with Neurotrophin-4/5
Introduction
Neurotrophins, including nerve growth factor (NGF),
brain-derived neurotrophic factor (BDNF), neurotrophin-
4/5 (NT-4/5), and neurotrophin-3 (NT-3), are a family of
Mark J. Banfield,1 Ruth L. Naylor,2
Alan G.S. Robertson,2 Shelley J. Allen,2
David Dawbarn,2 and R. Leo Brady1,3
1 Department of Biochemistry
University of Bristol
homologous proteins that tightly regulate the develop-Bristol BS8 1TD
ment and maintenance of the vertebrate neural system.United Kingdom
These molecules exert their effects through interactions2 Molecular Neurobiology Unit (Care of the Elderly)
with neuron cell surface receptors, of which two familiesUniversity Research Centre
have been identified (reviewed in [1]): the high-affinityfor Neuroendocrinology
and specific Trk receptors, and a generic, lower-affinityBristol Royal Infirmary
p75 receptor. All neurotrophins bind to the common p75Bristol BS2 8HW
receptor with similar affinity, but they show differentialUnited Kingdom
affinity toward the Trk receptors. Three forms of Trk
receptor (TrkA, TrkB, and TrkC) have been described.
TrkA forms a high-affinity binding site for NGF [2], TrkB
binds to BDNF and NT-4/5 [3, 4], and TrkC binds to NT-3Summary
[5]. NT-3 has also been shown to bind TrkA and TrkB
but with reduced affinity [6].Background: The binding of neurotrophin ligands to
All Trk receptors are homologous in sequence, eachtheir respective Trk cellular receptors initiates intracellu-
comprising about 800 amino acids with the amino termi-lar signals essential for the growth and survival of neu-
nal 400 residues forming the extracellular portion ofrons. The site of neurotrophin binding has been located
the receptor where binding of the neurotrophin takesto the fifth extracellular domain of the Trk receptor, with
place. Although the precise overall three-dimensionalthis region regulating both the affinity and specificity
structure of the entire extracellular fragment is notof Trk receptor:neurotrophin interaction. Neurotrophin
known, recognized sequence motifs have led to divisionfunction has been implicated in a number of neurological
of these receptors into five domains [7]: one 3 tandemdisorders, including Alzheimer’s disease and Parkin-
leucine-rich motif flanked by two cysteine cluster re-son’s disease.
gions (domains 1–3; d1–d3) followed by two immuno-
globulin superfamily (IgSF) domains (d4 and d5). Crystal-
lographic analyses of TrkA-d5, TrkB-d5, and TrkC-d5
Results: We have determined the 2.7 A˚ crystal structure
[8, 9] have confirmed this second IgSF domain adopts
of neurotrophin-4/5 bound to the neurotrophin binding an I set fold. It has also been suggested that neurotroph-
domain of its high-affinity receptor TrkB (TrkB-d5). As ins can bind both Trk receptors and p75 simultaneously
previously seen in the interaction of nerve growth factor and that Trk receptors and p75 may interact with each
with TrkA, neurotrophin-4/5 forms a crosslink between other [1, 10, 11]. An emerging consensus is that down-
two spatially distant receptor molecules. The contacts stream signaling events activated by the interaction of
formed in the TrkB-d5:neurotrophin-4/5 complex can neurotrophins with Trk receptors promote neuron sur-
be divided into a conserved area similar to a region vival, whereas activation of the p75 pathway triggers
observed in the TrkA-d5:NGF complex and a second apoptosis and cell death (reviewed in [1]).
site—unique in each ligand-receptor pair—formed pri- Although earlier studies [12–14] indicated that the sec-
marily by the ordering of the neurotrophin N terminus. ond leucine-rich motif of Trk receptors also regulated
neurotrophin binding, a recent crystal structure of NGF
bound to d5 of TrkA [15] suggested that domain 5 of
Conclusions: Together, the structures of the TrkB- Trk receptors is the site of neurotrophin binding. This
d5:NT-4/5 and TrkA-d5:NGF complexes confirm a con- is supported by work with chimeric Trk receptors [16,
sistent pattern of recognition in Trk receptor:neuro- 17] showing swapping of d5 between receptors, which
trophin complex formation. In both cases, the N terminus changes ligand specificity, and by mutational studies
of the neurotrophin becomes ordered only on complex [18, 19] illustrating the maintenance of neurotrophin-
formation. This ordering appears to be directed largely mediated signaling in truncated Trk receptors with only
by the receptor surface, with the resulting complemen- d5 in the extracellular region. Further, binding studies
tary surfaces providing the main determinant of receptor with recombinant TrkA domains indicate TrkA-d5 alone
specificity. These features provide an explanation both closely replicates the level of neurotrophin affinity ob-
for the limited crossreactivity observed between the served for the intact receptor [9, 20]. Under similar condi-
range of neurotrophins and Trk receptors and for the tions TrkA-d5 shows no significant binding to BDNF [9],
high-affinity binding associated with respective ligand- suggesting that domain 5 regulates both the affinity and
specificity of neurotrophin binding to Trk receptors.receptor pairs.
Key words: neurotrophin-4/5; TrkB; X-ray structure; neurodegener-
ative disease3 Correspondence: l.brady@bristol.ac.uk
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Figure 1. Structure of the TrkB-d5:NT-4/5 Complex
Views of the overall structure of the TrkB-d5:NT-4/5 complex are shown, each approximately orthogonal. The asymmetric unit of the crystal
contains a single copy of the TrkB-d5:NT-4/5 complex, comprising one homodimer of NT-4/5 bound to two monomers of TrkB-d5. The NT-
4/5 homodimer is colored red (one monomer) and blue (the second monomer) with various secondary structure elements labeled. TrkB-d5
monomers are colored cyan, and the  sheets are labeled. Also shown (yellow bonds) is NT-4/5 residue Arg-11 with TrkB residues Asp-298,
Cys-302, and Cys-345 (these highlight the location of the specificity interaction site), and also shown (violet bonds) are NT-4/5 residues Gln-
94 and Arg-114 with TrkB residues Asp-349 and Asn-350 (which highlight the location of the conserved interaction site). The model for the
TrkB-d5:NT-4/5 complex includes residues Gly-1 to Thr-127 for one NT-4/5 monomer and Thr-5 to Gly-128 for the second. TrkB-d5 residues
Ala-286 to Gly-383 inclusive are observed in both copies of the receptor domain. Figures 1–4 were all prepared with MOLSCRIPT [43] and
RASTER3D [44].
The crystal structure of the TrkA-d5:NGF complex was In this study, we report the crystal structure of the
related complex formed between the neurotrophin NT-determined from crystals prepared from a TrkA fragment
originally containing both domains 4 and 5, but from 4/5 and its specific Trk receptor, TrkB. Unlike in the
previous NGF-TrkA structure, a recombinant fragmentwhich the d4 fragment was fortuitously cleaved over an
extended period of time [15]. As only a portion of the of TrkB solely comprising residues in d5 has been used
to prepare the complex. This fragment reproduces thetruncated receptor was incorporated in the crystals, it
remained unclear whether interactions between NGF level of binding associated with the intact receptor, im-
plying that the neurotrophin binding site is wholly lo-and regions of TrkA outside of d5 might also be required
for complex formation. cated within this domain. The structure of this ligand-
Structure of TrkB-d5:NT-4/5 Complex
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Figure 2. Comparison of the Known Trk-Neu-
rotrophin Complexes
Stereo diagram showing the C traces of the
TrkB-d5:NT-4/5 (cyan and red, respectively)
and TrkA-d5:NGF (biege and blue, respec-
tively) complexes. The structures have been
overlaid by superimposing the neurotrophin
C atoms only. The overall similarity in the
architecture of the two complexes is appar-
ent, as is the displacement (calculated as 4
rotation) of the Trk-d5 domains relative to the
respective neurotrophin.
receptor pair shows a consistent mode of crosslinking crystallized as a strand-swapped homodimer in which
the A strand forms part of an adjacent molecule. FromTrk receptors by neurotrophins, expected to apply across
the whole homologous Trk family. Nonetheless, features this structure, the correctly folded monomeric TrkB-d5
domain can be extrapolated by reconnecting the poly-that delineate affinity and specificity for the individual
Trk receptor:neurotrophin pairs are also evident. peptide chain at the A/B loop and assuming no other
changes. A comparison of this monomeric, unliganded
form of TrkB-d5 with the same domain present in theResults and Discussion
TrkB-d5:NT-4/5 complex shows that its structure does
not change significantly on complex formation (rmsdFigure 1 shows the crystal structure of the complex
0.46 A˚ for 97 equivalent C positions) in common withformed between the neurotrophin NT-4/5 and the sec-
the comparison of the unliganded [8, 9] and ligandedond immunoglobulin domain (d5) of the TrkB receptor.
[15] forms of TrkA-d5.The bound neurotrophin homodimer ligand forms a
In contrast, substantial but localized changes are ob-bridge between two receptor molecules, with extensive
served between the unliganded and liganded structuresintermolecular contacts stabilizing the complex.
for the NT-4/5 molecule. Although the overall fold is
maintained (rmsd of the dimer is 0.83 A˚ for 180 CTrkB-d5 Is the Site of NT-4/5 and BDNF Binding
positions), significant conformational changes are seenWe have previously shown that TrkA-d5 binds to NGF
in the residues located at the N terminus, the L2 loop,with a similar affinity to the intact TrkA receptor [9],
the loop between residues 63 and 70, the L4 loop, anddemonstrating that the major contributions to NGF bind-
the C terminus (see Ref. 22 for loop definitions). Mosting arise from the d5 domain. Using surface plasma
of these changes appear to result from the differingresonance, recombinant TrkB-d5 has been shown to
degrees of mobility of these loop regions in the twobind NT-4/5 with a Kd of 260 pM and to bind BDNF with
different crystal lattices and are unlikely to be directlya Kd of 790 pM, whereas no binding of NGF is observed
attributable to complex formation. However, one notableup to concentrations of 100 nM (R.L. Naylor et al., sub-
exception is the N terminus. Mutational studies indicatemitted). The association constant for BDNF with TrkB-d5
that this region is an important determinant in Trk:neuro-is comparable to that reported with the intact receptor at
trophin affinity and specificity [6, 23], but this segmentthe cell surface (990 pM [21]), confirming that d5 alone
is always disordered in the structures of unligandedcan account for neurotrophin-receptor binding, as seen
forms of the neurotrophins. In the crystal structure offor the interaction of TrkA-d5 with NGF [9]. While the
the TrkB-d5:NT-4/5 complex, all of the amino-terminalaffinity of the intact TrkB receptor for NT-4/5 at the cell
residues from Gly-1 are visible for one NT-4/5 monomersurface has not been directly measured, it would be
and from Thr-5 in the second. In both cases a short 310expected to be similar to BDNF, and we therefore pre-
helix is formed by residues Ala-7–Arg-11. These resi-sume that the Kd of 260 pM observed for the TrkB-
dues are in intimate contact with TrkB-d5, as discussedd5:NT-4/5 interaction is most likely equivalent to the
below.affinity of the intact receptor. The solvent-accessible
surface area buried between one receptor domain and
the neurotrophin in the TrkB-d5:NT-4/5 complex is Table 1. Data Collection Statistics for the TrkB-d5:NT-4/5
Complex Crystal2217 A˚2, similar to the buried area reported for the TrkA-
d5:NGF complex and for other tightly associated protein TrkB-d5:NT-4/5 Data
complexes. The striking similarity in the arrangement
Unit cell a  74.4 A˚, b  80.4 A˚,of the components within these separate complexes
c  91.3 A˚
(Figure 2) is consistent with the d5 domain of the Trk Space group P212121
receptors forming the major, and most likely the exclu- Wavelength (A˚) 1.488
sive, binding interface with neurotrophins. Resolution range (A˚) 30–2.7 (2.8–2.7)
Number of unique reflections 15,635
Redundancy 5.4 (5.4)Complex Formation Stabilizes the Neurotrophin
Completeness (%) 99.2 (99.9)
Amino Terminus Rmerge (%) 8.4 (29.4)
The crystal structures of TrkB-d5 [8] and human NT- (I)/(I) 19.6 (3.7)
4/5 [22] have both been previously determined in their
Figures in parentheses are for the highest resolution shell.
unliganded forms. TrkB-d5, however, has only been
Structure
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Table 2. Refinement Statistics for the TrkB-d5:NT-4/5 Complex Structure
TrkB-d5:NT-4/5 Data
Resolution (A˚) 20–2.7 (2.8–2.7)
Rcryst (%) 21.8 (29.9)
Rfree (%) 26.4 (35.9)
Rmsd bond lengths (A˚) 0.007
Rmsd bond angles () 1.42
Total number of nonhydrogen protein atoms 3,503
Number of solvent atoms 80
Overall B value for protein (A˚2) 46.7
Overall B value for solvent residues (A˚2) 51.7
Rmsd bonded B (main chain/side chain) (A˚) 1.5/2.0
Coordinate error (A˚) 5.0–2.7
Luzzati (crossvalidated Luzzati) 0.32 (0.42)
Sigmaa (crossvalidated sigmaa) 0.33 (0.44)
Figures in parentheses are for the highest resolution shell; rmsd refers to the root-mean-square deviation.
From Figures 1 and 2 it is evident that the overall (the “conserved patch,” see below) appears to act as a
hinge for this apparent rotation, with the “specificityarchitecture of the TrkB-d5:NT-4/5 complex is similar to
that previously described for TrkA-d5:NGF. This dispels patch,” and in particular the neurotrophin amino termi-
nus, driving the displacement.any concerns that the earlier structure was unduly influ-
enced by the crystal environment and establishes a
common binding arrangement for neurotrophins to their Interactions Forming the TrkB-d5:NT-4/5 Complex
In common with the TrkA-d5:NGF complex, contactsTrk receptors. When the two complexes are overlaid, a
subtle reorientation of the receptor domains is evident. between TrkB-d5 and NT-4/5 occur in two separate simi-
larly sized regions (Figure 1). One contact region isWhereas the neurotrophin homodimer acts as a rigid
unit, a small rotation (4 relative to the equivalent TrkA formed by residues from the AB, CD, and EF loops and
C terminus of TrkB-d5, interfacing with amino acids fromlocations) is observed for each of the TrkB receptor
domains. Even when the limited resolution (2.7 A˚; for the central stalk strand A from one NT-4/5 monomer, and
by strands C/D from the second neurotrophin monomerdetails of data collection and refinement see Tables 1
and 2) of the current crystal structure is considered, this (Figure 3a) and the L1 loop from a single monomer. The
second contact region is formed between one chain ofis a significant change that results in typical displace-
ments of equivalent C positions on the external faces the neurotrophin homodimer and one receptor domain,
involving the N-terminal residues of NT-4/5 and the ex-of the receptors of about 2 A˚. These changes are most
pronounced at sites distant from the neurotrophin:d5 ternal face of the TrkB-d5 ABED  sheet (Figure 3b).
These regions correspond to those described for theinterface, where they could alter any contacts made by
these regions with either other portions of the intact Trk TrkA-d5:NGF complex in which the first region was
termed the conserved patch and the second, the speci-receptor or with other cell surface molecules. Intrigu-
ingly, one portion of the neurotrophin:receptor interface ficity patch.
Figure 3. Contacts Formed in the TrkB-
d5:NT-4/5 Complex
Contacts formed at (a) the conserved patch
and (b) the specificity patch.
Stereo views showing fragments of the TrkB-
d5 C trace in cyan and those of the NT-4/5
C trace in red and blue. Secondary structure
features and relevant amino acids are la-
beled. In (b), TrkB-d5 strands shown are
ABED from bottom to top. Bonds in individual
residues are shown in khaki for TrkB and light
gray for NT-4/5. Intermolecular hydrogen
bonds are displayed as dashed lines.
Structure of TrkB-d5:NT-4/5 Complex
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The Conserved Patch the bottom of a shallow pocket (Figure 3b). The hy-
drophobic portion of the Arg-11 side chain lies acrossThe majority of contacts in the conserved patch are
the disulphide, with the guanidinium group forming amediated through the EF loop of TrkB-d5, binding to
salt bridge with Asp-298. The Arg-10 side chain stacksthe stalk of the NT-4/5 molecule. The importance of this
against the ring of His-343 on TrkB-d5. There is also aregion has been previously demonstrated with mutation
main chain hydrogen bond formed between the carbonylexperiments on TrkA and TrkC [18]. TrkB-d5 residues
oxygen of Glu-13 (NT-4/5) and His-299 (TrkB-d5). OtherAsp-349 and Asn-350 form a network of hydrogen bonds
NT-4/5 residues within van der Waals contact of thewith Gln-94, Tyr-96, and Arg-114 on NT-4/5 (Figure 3a).
receptor include Gly-1, Ser-3, Glu-4, Ala-6, Ser-9, andThe latter residue (Arg-114) is conserved in all neuro-
Leu-14.trophins and was shown to be the most important deter-
Whereas the surface of the receptor in this region isminant in the binding of TrkC to NT-3 [6]. The guanidi-
similar in both TrkA and TrkB—both in their unligandednium group of Arg-114 also packs alongside the
and complexed states—the liganded conformation ofhydrophobic ring of Tyr-329 of TrkB-d5 (on the CD
the neurotrophins differ substantially between NT-4/5loop). The contacts made through the AB and C-terminal
and NGF. The latter adopts a single turn of  helix foldingregions of TrkB-d5 are primarily van der Waals in nature;
down onto the ABED sheet (Figure 4). The equivalentthe CD and EF loops are also in van der Waals contact
region from NT-4/5, however, adopts a different pathwith NT-4/5.
and forms a single turn of 310 helix. (Figures 3b and 4).Consistent with the broad similarity of amino acids
As these regions are disordered in the unliganded forms,forming the conserved patch on both the neurotrophin
there must be an entropic cost to complex formationand Trk receptor faces, a comparison of the TrkB-d5:NT-
that is presumably compensated through the provision4/5 and TrkA-d5:NGF complexes shows no significant
of complementary pockets on the receptor surfaces sta-differences in the protein main chain conformations be-
bilizing a preferred conformation for each N-terminaltween the TrkA and TrkB domains or between the two
region. The peripheral stability conferred upon the neu-neurotrophins. Nonetheless, there are some noteworthy
rotrophin N terminus is emphasized by the observationdifferences in the vicinity of the conserved arginine resi-
that residues 1–4 are disordered in one copy of thedue (114 in NT-4/5, 103 in NGF) that suggest that a
molecule within the crystal lattice, and the temperaturedegree of the specificity in Trk:neurotrophin interaction
factors remain higher than average up to residue 10 on
may be achieved through discrimination at this site. In
both chains of the homodimer.
the TrkA-d5:NGF complex, a number of prominent hy-
In the TrkA-d5:NGF complex, the short  helix formed
drogen bonds are observed between the neurotrophin by the N-terminal residues of NGF places the side chain
and receptor in this region. These involve His-84 and of Ile-6 into an almost exclusively hydrophobic pocket
Arg-103 from NGF and Asn-349 and Gln-350 from the on the ABED face of TrkA-d5, with the exposed disul-
TrkA-d5 receptor. Although the arginine is conserved in phide at its base. In the TrkB-d5:NT-4/5 complex, the
NT-4/5, the identity of many of the other amino acids in equivalent pocket is occupied by the Arg-11 side chain
this contact site has altered. The arginine side chain from NT-4/5. The hydrophobicity of the pocket is re-
adopts a different conformation, and a complementary duced through the substitution of residues forming its
series of neurotrophin-receptor hydrogen bond pairs are walls—Val-294 in TrkA is replaced with Thr (296, TrkB
formed, involving Gln-94, Tyr-96, and Arg-114 from NT- numbering), Met-296 is replaced with Asp (298). In con-
4/5 and residues Asp-349 and Asn-350 from TrkB-d5 trast to the limited hydrophobic interactions made by
(Figure 3a). In this way, despite substantial shuffling of the Ile-6 side chain from NGF to TrkA, in the same loca-
amino acid side chains within parts of this conserved tion the guanidinium group from Arg-11 of NT-4/5 forms
ligand-receptor interface, the association between the a very specific salt bridge with Asp-298 from TrkB (Fig-
two molecules in this region is closely maintained. This ure 4). These different binding arrangements for the
shuffling of surfaces may reduce crossreactivity between N-terminal region were not expected since Arg-11 is
neurotrophins and permit fine tuning of Trk:neurotrophin conserved in all of the neurotrophins.
specificity (as has been suggested for TrkA and TrkC Two other changes in and around the specificity patch
specificity for their respective high-affinity ligands [18]). may potentially also contribute to ligand discrimination.
In the TrkA-d5:NGF complex, the side chain of Glu-13
(NGF) forms an intermolecular hydrogen bond to Arg-
The Specificity Patch 347 on TrkA-d5. This arrangement is disrupted in TrkB-
The lack of sequence conservation in both the Trk recep- d5:NT-4/5, where the receptor arginine is mutated to a
tors and the neurotrophins at the second site of interac- glutamine, and the intermolecular hydrogen bond ob-
tion led to the suggestion that this region could be the served in the TrkA-d5:NGF complex is replaced by an
primary determinant for specificity [15]. This was sup- intramolecular interaction between Glu-13 and Lys-91
ported by earlier experimental evidence in which re- of the same NT-4/5 dimer. Second, a 2 residue deletion
placement of the N-terminal region of NT-3 with the in the DE loop of TrkB relative to TrkA leads to a new
equivalent NGF sequence resulted in a protein that binds conformation for this region, which lies immediately ad-
to both TrkA and TrkC with high affinity [6]. jacent to the specificity patch.
In the TrkB-d5:NT-4/5 complex, the most important
contacts in the specificity patch are made by NT-4/5 Achieving Specificity in Trk:Neurotrophin
residues Arg-11 and Arg-10. Arg-11 primarily interacts Interaction
with TrkB-d5 residues Asp-298 and the two cysteines There are now crystal structures for two pairs of Trk
receptors bound to their neurotrophins, as well as unli-(302 and 345) that form an exposed disulphide bond at
Structure
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Figure 4. Stereo View Comparing Interac-
tions at the Specificity Patch between the
TrkB-d5:NT-4/5 and TrkA-d5:NGF Com-
plexes
C traces in the TrkB-d5:NT-4/5 complex are
shown in cyan (TrkB-d5) and red (NT-4/5),
and in the TrkA-d5:NGF complex as biege
(TrkA-d5) and blue (NGF). Individual residues
shown are Glu-4, Thr-5, Ala-6, Arg-10, and
Arg-11 of NT-4/5 (light gray); Ser-2, Ser-3,
Pro-5, Ile6, His-8, and Arg-9 of NGF (dark
gray); Asp-298, Cys-302, and Cys-345 of TrkB
(khaki); and Met-296, Cys-300, and Cys-345
of TrkA (violet).
ganded structures for d5 from TrkA, TrkB, and TrkC and lacks a suitable hydrogen bonding partner for Arg-11
from NT-4/5, and access for the extended arginine sidethe unliganded forms of NGF [24], BDNF (as one half
of a heterodimer [22]), NT-4/5 [22], and NT-3 [25]. In chain is further blocked by Met-296 (Asp-298 in TrkB).
Occlusion of Arg-11 from this site limits the repertoirecombination these structures describe a consistent
model for neurotrophin binding. Binding of the homodi- of conformations that can be adopted by the remainder
of the N-terminal peptide, presumably preventing furthermeric neurotrophins is primarily a function of the d5
region of the receptors. A pseudosymmetric complex is complementation with the TrkA surface. In the absence
of its side chain being accommodated within thisformed, leading to recruitment and dimerization of two
separate molecules of the Trk cell surface receptor with pocket, the C atom of Arg-9 (NGF) is displaced by
5.2 A˚ from its equivalent position in the TrkB-d5:NT-4/5their colocalization assumed to trigger downstream sig-
naling activity. Ligand binding results from a set of rela- complex (Arg-11).
A comparison of the TrkA-d5:NGF and TrkB-d5:NT-tively conserved contacts, common throughout the re-
ceptor family, and a second set of highly specific 4/5 structures also suggests why NGF shows no signifi-
cant binding to TrkB. It is possible to rebuild the N terminuscontacts. This latter set is intriguing, since it appears
that the surface contributed by the neurotrophin is only of NGF to that observed for NT-4/5 in the TrkB-d5:NT-4/5
complex, and this does not result in any obvious clashesformed along with the complex. It appears likely that
the N-terminal region of the neurotrophins adopts an that might prevent complex formation. However, in this
theoretical conformation both of the hydrophobic resi-ensemble of structures in its unliganded form, with stabi-
lization of a particular secondary structure being encour- dues Ile-6 and Phe-7 are solvent exposed. This unfavor-
able conformation would be expected to destabilize in-aged when associated with complementary pockets on
the receptor surface. Although helical conformations are teractions between TrkB and NGF, potentially explaining
the much-reduced affinity of NGF for TrkB compared toobserved for these regions in both complexes, attempts
to predict these conformations in the unliganded neuro- NT-4/5. Although the neurotrophin amino terminus is
disordered in the absence of receptor, it is also possibletrophin using the helical predicting software AGADIR
[26] or the peptide conformation software RAFT [27] that the 310-helical conformation required for comple-
mentation with the TrkB surface is not favored by theshowed no inherent tendency toward helical conforma-
tion for these peptide sequences. This is consistent with peptide sequence.
Despite conservation of an arginine in the N-terminalthe disorder observed in all unliganded neurotrophin
crystal structures, implying that secondary structure is region (NT-4/5:Arg-11, NGF:Arg-9) of all neurotrophins,
its placement within the receptor complexes varies dra-only adopted in these regions on complex formation.
Crossreactivity is a feature of several neurotrophin:Trk matically along with the flanking amino terminal peptide
conformation. This complicates predicting the details ofreceptor combinations, and may reflect the relative de-
formability of the specificity region. other neurotrophin:Trk receptor complexes. However,
TrkB also binds BDNF with high affinity. As NT-4/5 andStructural and functional studies of the human growth
hormone bound to its receptor [28, 29] have suggested BDNF share ten of the twelve residues involved in the
conserved patch and five of seven within the specificitythat most of the binding was facilitated by a relatively
small number of interface residues. Similarly, within the patch, it seems very likely that the association within
the TrkB-d5:BDNF complex will mimic that of TrkB-neurotrophin:Trk receptor family it appears that small
surface changes lead to highly specific ligand discrimi- d5:NT-4/5. BDNF is therefore expected not to bind TrkA
for the same reasons discussed for NT-4/5 above.nation. For instance, NGF displays no significant binding
to TrkB-d5—the identities of only five of the twelve con- It is more difficult, however, to predict the details of
TrkC-d5 binding to NT-3, since for both molecules theretact residues in the conserved patch are maintained
(although many of the differences are mutations to ho- is much less conservation of residues that form both
the conserved and specificity patches. Crucially, an argi-mologous residues) and three of the seven sites within
the specificity patch. The notion that the receptor sur- nine in TrkC at position 298 seems likely to prevent the
N terminus of NT-3 from adopting either of the conforma-face at least partially dictates the allowed conformations
for the neurotrophin amino terminus can be used to tions observed for liganded NT-4/5 or NGF. The N termi-
nus of NT-3 has been shown to be less influential forexplain the lower-affinity binding of NT-4/5 to TrkA-d5
in contrast to NGF. The specificity pocket of TrkA-d5 both the affinity and specificity of binding to its Trk
Structure of TrkB-d5:NT-4/5 Complex
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receptor [6]. This raises the possibility that the majority tive families, they display differential binding affinity
such that TrkA forms the high-affinity binding site forof contacts in a TrkC:NT-3 complex are made through
the conserved patch, with the amino terminal region of NGF, TrkB binds to BDNF and NT-4/5, and TrkC binds to
NT-3. The neurotrophin binding site on the Trk receptorsthe neurotrophin remaining at least partially disordered.
Intriguingly, the TrkC:NT-3 interaction has been de- has been located to the fifth extracellular domain (d5).
In this study we have described the structure of NT-scribed as the most specific among the Trk:neurotrophin
pair [5], implying that reliance on a potentially deform- 4/5 bound to the neurotrophin binding domain of its
high-affinity receptor, TrkB (TrkB-d5). This is the secondable region could moderate rather than enhance dis-
crimination. example of a Trk receptor:neurotrophin complex to be
described, and for the first time allows a comparison of
the interactions that differentiate Trk receptor:neuro-Potential for Specific Therapeutics
trophin pairs. These interactions can be divided intoNeurotrophin function has been suggested to be in-
two contact regions. One is characterized by a set ofvolved in a number of neurological disorders including
relatively conserved interactions, seen also in the TrkA-Alzheimer’s disease, Parkinson’s disease [30–32], Hunt-
d5:NGF complex and predicted to be similar in otherington’s disease [33], and epilepsy [34]. The interaction
pairs. This consistency is thought to underlie the signifi-of neurotrophins with their receptors provides a focus
cant crossreactivity observed between certain Trk recep-for the potential development of therapeutics to these
tor:neurotrophin pairs. Contacts in the second region differdisorders. Preliminary trials in which murine NGF has
significantly between the TrkA-d5:NGF and TrkB-d5:NT-been administered directly to Alzheimer’s patients by
4/5 pairs. This region is primarily formed by contactsintracerebroventricular infusion have produced limited
that lead to ordering of the neurotrophin N terminus, aimprovements to cognitive function [35], but the treat-
region that is disordered in all unliganded neurotrophinment requires expensive invasive surgery. The crystal
structures. Mutagenesis studies of amino acids in thisstructures of the TrkA-d5:NGF and TrkB-d5:NT-4/5 pairs
region have previously indicated the importance of thismay assist the further development of small-molecule
region in determining the specificity of Trk:neurotrophinneurotrophin mimetics.
interactions. The convenient division of these ligand-Nonetheless, the picture emerging for Trk stimulation
receptor pairs into conserved and specificity contactis complex. Even if the role played by the neurotrophins
regions implies that it may be feasible to engineeringis restricted to the crosslinking of receptor pairs, it is
neurotrophins to provide universal binding across thedifficult to envisage the design of small molecules capa-
Trk receptor family.ble of both binding and maintaining the spatial separa-
tion of receptor domains observed in these two com-
Experimental Proceduresplexes. In both cases binding of neurotrophin holds the
receptor domains at a minimal separation of 23 A˚, a Protein Purification and Crystallization
distance that may be crucial for correct phosphorylation Recombinant TrkB-d5 was expressed in E. coli and purified to homo-
geneity as described in R.L. Naylor et al. (submitted). Briefly, inclu-of the intracellular kinase domain. The extended surface
sion bodies containing TrkB-d5 were purified by washing with so-created by the Trk:neurotrophin assembly might alterna-
dium phosphate buffer (pH 8.5) containing in succession, 0.1 Mtively form the basis for further interaction with other
NaCl, 1% Triton X-100, and 1 M NaCl. The inclusion bodies wereaccessory molecules. Previous studies indicated neuro-
then solubilized in the same buffer with the addition of 8 M urea.
trophins may simultaneously bind both their Trk and TrkB-d5 was purified under denaturing conditions on a HiTrap che-
p75 receptors [10]. The potential involvement of other lating column precharged with nickel. The protein was refolded by
removal of the urea on a S200 gel-filtration column; the fractionscomponents also provides the possibility that the small
comprising the peak eluting at the approximate molecular weightangular rotations observed in the association of Trk-d5
of monomeric TrkB-d5 were pooled. NT-4/5 was a kind gift fromdomains to their neurotrophins might lead to a gradation
Abraham de Vos (Genentech, USA). For crystallization trials, theof activity regulated by the association properties of
complex between TrkB-d5 and NT-4/5 was formed by mixing equi-
each Trk:neurotrophin complex. molar quantities of TrkB-d5 (in 25 mM HEPES, 100 mM NaCl [pH
The crystal structures of the TrkA-d5:NGF and TrkB- 8.0]) with NT-4/5 (in 10 mM sodium acetate, 140 mM NaCl [pH 4.0]),
then incubating overnight at 4C. A low protein concentration wasd5:NT-4/5 complexes illustrate a common activation
maintained to avoid the formation of nonnative oligomeric formsmechanism for Trk receptors by neurotrophins. The ob-
of the Trk-d5 domain [8]. The resulting solution was concentratedservation that only a limited number of contacts deter-
(formation of the Trk:neurotrophin complex protects the Trk-d5 do-mine the specificity in each neurotrophin:Trk pair raises
main from adopting nonnative oligomeric states) and loaded onto an
the possibility that a universal neurotrophin therapeutic, S75 gel filtration column to separate the complex from any unbound
capable of activating all Trk receptors, could be de- components. The complex eluted as a single peak in 20 mM Tris,
150 mM NaCl (pH 7.5) and was concentrated to 10 mg/ml (allsigned.
protein concentrations were calculated from absorbance of the so-
lution at 280 nm).
Biological Implications A number of TrkB-d5 constructs were used in the crystallization
screens. These included residues 286–430 of the intact protein, with
and without the 21 residue N-terminal His tag derived from theDefining the key interactions formed between the neuro-
expression vector (the His tag was cleaved with Thrombin), and thetrophins and their cellular receptors is an important step
residues 286–384 of TrkB. Only crystals of the latter construct werein understanding the pathways involved in the develop-
obtained using commercially available screens. Optimization of
ment and maintenance of the vertebrate neural system. these initial conditions yielded diffraction quality crystals from a 1:1
Although the neurotrophins and the Trk receptors share mixture of 10 mg ml1 complex solution and 1.5–1.6 M LiSO4, 100 mM
HEPES (pH 7.0–7.5). For data collection crystals were progressivelysequence and structural homology within their respec-
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soaked for 10 min in 5%, 10%, 15%, 20%, and then 25% glycerol, functional interactions between the neurotrophin receptors trk
and p75NTR. EMBO J. 18, 616–622.prior to freezing in a liquid nitrogen cold stream. Diffraction data
were collected on station 14.1 at the Daresbury-SRS to 2.7 A˚ resolu- 12. Windisch, J.M., Marksteiner, R., and Schneider, R. (1995). Nerve
growth factor binding site on TrkA mapped to a single 24-aminotion at 100 K. All data processing was carried out with the HKL
suite [36]. A summary of data collection and crystal parameters is acid leucine-rich motif. J. Biol. Chem. 270, 28133–28138.
13. Windisch, J.M., Auer, B., Marksteiner, R., Lang, M.E., andpresented in Table 1.
The structure was solved by molecular replacement using AmoRe Schneider, R. (1995). Specific neurotrophin binding to leucine-
rich motif peptides of TrkA and TrkB. FEBS Lett. 374, 125–129.[37] as implemented in CCP4 [38]. Rotation searches used the homo-
dimer of NT-4/5 (Protein Data Bank code 1B98) and a model of Trk- 14. Windisch, J.M., Marksteiner, R., Lang, M.E., Auer, B., and
Schneider, R. (1995). Brain-derived neurotrophic factor, neuro-d5 monomer based on the published strand-swapped dimer (PDB
code 1WWB). Translation searches with the NT-4/5 dimer generated trohin-3 and neurotrophin-4 bind to a single leucine-rich motif
of TrkB. Biochemistry 3, 11256–11263.a single clear peak (as expected) that was the top rotation solution.
Subsequent translation searches with the TrkB-d5 monomer (NT- 15. Wiesmann, C., Ultsch, M.H., Bass, S.H., and deVos, A.M. (1999).
Crystal structure of nerve growth factor in complex with the4/5 dimer position fixed) gave two clear translation solutions (as
ligand-binding domain of the TrkA receptor. Nature 401,expected), which were the first and sixteenth peaks from the rotation
184–188.function. The combined solutions were then subjected to rigid-body
16. Perez, P., Coll, P.M., Hempstead, B.L., Martinzanca, D., andrefinement.
Chao, M.V. (1995). NGF binding to the Trk tyrosine kinase recep-The structure was refined with REFMAC [38, 39] and CNS [40],
tor requires the extracellular immunoglobulin-like domains. Mol.with cycles of manual model building performed with O [41]. The
Cell. Neurosci. 6, 97–105.first round of refinement including all data from 20–2.7 A˚ resolution
17. Urfer, R., Tsoulfas, P., O’Connell, L., Shelton, D.L., Parada, L.F.,reduced Rcryst to 30.6% and Rfree [42] to 33.7%. Repeated cycles of
and Presta, L.G. (1995). An inmmunoglobulin-like domain deter-refinement and rebuilding have lowered the R factors to the current
mines the specificity of neurotrophin receptors. EMBO J. 14,values of Rcryst (21.8%) and Rfree (26.4%). A summary of the refinement
2795–2805.statistics is presented in Table 2.
18. Urfer, R., Tsoulfas, P., O’Connell L, Hongo J.-A., Zhao W., and
Presta, L.G. (1998). High resolution mapping of the binding siteAcknowledgments
of TrkA for nerve growth factor and TrkC for neurotrophin-3 on
the second immunoglobulin-like domain of the Trk receptors.The authors thank the Wellcome Trust for supporting this research.
J. Biol. Chem. 273, 5829–5840.A.G.S.R. and S.J.A. are Sigmund Gestetner fellows. The authors
19. O’Connell, L., Hongo, J.-A., Presta, L.G., and Tsoulfas, P. (2000).also thank Abraham de Vos (Genetech Inc., USA) for his kind and
TrkA amino acids controlling specificity for nerve growth factor.generous gift of the NT-4/5 and the staff at the Daresbury-SRS for
J. Biol. Chem. 275, 7870–7877.their help with data collection.
20. Holden, P.H., et al., and Dawbarn, D. (1997). Immunoglobulin
domains define the nerve growth factor binding site of the TrkAReceived: August 31, 2001
receptor. Nat. Biotechnol. 15, 668–672.Accepted: October 18, 2001
21. Dechant, G., Biffo, S., Okazawa, H., Kolbeck, R., Pottgiesser,
J., and Barde, Y.-A. (1993). Expression and binding characteris-
References tics of the BDNF receptor chick TrkB. Development 119,
545–558.
1. Bibel, M., and Barde, Y.-A. (2000). Neurotrophins: key regulators 22. Robinson, R.C., et al., and Jones, E.Y. (1999). The structures of
of cell fate and cell shape in the vertebrate nervous system. neurotrophin 4 homodimer and the brain-derived neurotrophic
Genes Dev. 14, 2919–2937. factor/neurotrophin 4 heterodimer reveal a common Trk-binding
2. Martin-Zanca, D., Oskam, R., Mitra, G., Copeland, T., and Bar- site. Protein Sci. 8, 2589–2597.
bacid, M. (1989). Molecular and biochemical-characterization 23. McInnes, C., and Sykes, B.D. (1997). Growth factor receptors:
of the human trk proto-oncogene. Mol. Cell. Biol. 9, 24–33. structure, mechanism, and drug discovery. Biopolymers 43,
3. Ip, N.Y., et al., and Yancopoulos, G.D. (1993). Similarities and 339–366.
differences in the way neurotrophins interact with the trk recep- 24. McDonald, N.Q., Lapatto, R., Murrayrust, J., Gunning, J., Wlo-
tors in neuronal and nonneuronal cells. Neuron 10, 137–149. dawer, A., and Blundell, T.L. (1991). A new protein fold revealed
4. Klein, R., Lamballe, F., Bryant, S., and Barbacid, M. (1992). The by a 2.3 A˚ resolution crystal structure of nerve growth factor.
trkB tyrosine protein-kinase is a receptor for neurotrophin-4. Nature 354, 411–414.
Neuron 8, 947–956. 25. Butte, M.J., Hwang, P.K., Mobley, W.C., and Fletterick, R.J.
5. Lamballe, F., Klein, R., and Barbacid, M. (1991). TrkC, a new (1998). Crystal structure of neurotrophin-3 homodimer shows
member of the trk family of tyrosine protein-kinases, is a recep- distinct regions are used to bind its receptors. Biochemistry 37,
tor for neurotrophin-3. Cell 66, 967–979. 16846–16852.
6. Urfer, R., Tsoulfas, P., Soppet, D., Escandon, E., Parada, L.F., 26. Lacroix, E., Viguera, A.R., and Serrano, L. (1998). Elucidating
and Presta, L.G. (1994). The binding epitopes of neurotrophin-3 the folding problem of -helices: local motifs, long range elec-
to its receptors trkc and gp75 and the design of a multifunctional trostatics, ionic strength dependence and prediction of NMR
human neurotrophin. EMBO J. 13, 5896–5909. parameters. J. Mol. Biol. 284, 173–191.
7. Schneider, R., and Schweiger, M. (1991). A novel modular mo- 27. Gibbs, N., Clarke, A.R., and Sessions, R.B. (2001). Ab initio
saic of cell-adhesion motifs in the extracellular domains of the protein structure prediction using physicochemical potentials
neurogenic trk and trkb tyrosine kinase receptors. Oncogene and a simplified off-lattice model. Proteins. 43, 186–202.
6, 1807–1811. 28. de Vos, A.M., Ultsch, M., and Kossiakoff, A.A. (1992). Human
8. Ultsch, M.H., et al., and de Vos, A.M. (1999). Crystal structures growth hormone and the extracellular domain of its receptor—
of the neurotrophin-binding domain of TrkA, TrkB and TrkC. J. crystal structure of the complex. Science 255, 306–312.
Mol. Biol. 290, 149–159. 29. Clackson, T., Ultsch, M.H., Wells, J.A., and de Vos, A.M. (1998).
9. Robertson, A.G.S., et al., and Dawbarn, D. (2001). Identification Structural and functional analysis of the 1:1 growth hormone:
and structure of the nerve growth factor binding site on TrkA. receptor complex reveals the molecular basis for receptor activ-
Biochem. Biophys. Res. Commun. 282, 131–141. ity. J. Mol. Biol. 277, 1111–1128.
10. Mahadeo, D., Kaplan, L., Chao, M.V., and Hempstead, B.L. 30. Allen, S.J., Wilcock, G.K., and Dawbarn, D. (1999). Profound and
(1994). High affinity nerve growth factor binding displays a faster selective loss of catalytic TrkB immunoreactivity in Alzheimer’s
rate of association than P140(Trk) binding—implications for disease. Biochem. Biophys. Res. Commun. 264, 648–665.
multisubunit polypeptide receptors. J. Biol. Chem. 269, 6884– 31. Siegel, G.J., and Chauhan, N.B. (2000). Neurotrophic factors in
6891. Alzheimer’s and Parkinson’s disease brain. Brain Res. Rev. 33,
199–227.11. Bibel, M., Hoppe, E., and Barde, Y.-A. (1999). Biochemical and
Structure of TrkB-d5:NT-4/5 Complex
1199
32. Murer, M.G., Yan, Q., and Raisman-Vozari, R. (2001). Brain de-
rived neurotrophic factor in the control human brain, and in
Alzheimer’s disease and Parkinson’s disease. Prog. Neurobiol.
63, 71–124.
33. Perez-Navarro, E., Canudas, A.M., Akerud, P., Alberch, J., and
Arenas, E. (2000). Brain-derived neurotrophic factor, neuro-
trophin-3, and neurotrophin-4/5 prevent the death of striatal
projection neurons in a rodent model of Huntington’s disease.
J. Neurochem. 75, 2190–2199.
34. Mathern, G.W., Babb, T.L., Micevych, P.E., Blanco, C.E., and
Pretorius, J.K. (1997). Granule cell mRNA levels for BDNF, NGF,
and NT-3 correlate with neuron losses or supragranular mossy
fibre sprouting in the chronically damaged and epileptic human
hippocampus. Mol. Chem. Neuropathol. 30, 53–76.
35. Jonhagen, M.E., et al., and Wahland, L.O. (1998). Intracerebro-
ventricular infusion of nerve growth factor in three patients with
Alzheimer’s disease. Dement. Geriatr. Cogn. Disord. 9, 246–257.
36. Otwinowski, Z., and Minor, W. (1996). Processing of X-ray dif-
fraction data collected in oscillation mode. In Methods in Enzy-
mology, Volume 276, C.W. Carter, Jr. and R.M. Sweet, eds. (New
York: Academic Press), pp. 307–326.
37. Navaza, J. (1994). AMoRe – an automated package for molecular
replacement. Acta Crystallogr. A 50, 157–163.
38. CCP4 (Collaborative Computational Project 4) (1994). The CCP4
suite: programs for protein crystallography. Acta Crystallogr. D
50, 760–763.
39. Murshudov, G.N., Vagin A.A., and Dodson, E.J. (1997). Refine-
ment of macromolecular structures by the maximum-likelihood
method. Acta Crystallogr. D, 53, 240–255.
40. Bru¨nger, A.T., et al., and Warren, G.L. (1998). Crystallography &
NMR system: a new software suite for macromolecular structure
determination. Acta Crystallogr. D 54, 905–921.
41. Jones, T.A., Zou, J.-Y., Cowan, S.W., and Kjeldgaard, M. (1991).
Improved methods for binding protein models in electron den-
sity maps and the location of errors in these models. Acta Crys-
tallog. A 47, 110–119.
42. Bru¨nger, A.T. (1992). The free R value: a novel statistical quantity
for assessing the accuracy of crystal structures. Nature 355,
472–474.
43. Kraulis, P.J. (1991). MOLSCRIPT: a program to produce both
detailed and schematic plots of protein structures. J. Appl.
Cryst. 24, 946–950.
44. Meritt, E.A., and Bacon, D.J. (1997). Raster3D photorealistic
molecular graphics. In Methods in Enzymology, Volume 277,
C.W. Carter, Jr. and R.M. Sweet, eds. (New York: Academic
Press), pp. 505–524.
Accession Numbers
Coordinates and structure factors for the TrkB-d5:NT-4/5 complex
have been deposited with the Protein Data Bank with accession
codes 1HCF and R1HCFSF.
